ProGnosis Biotech SA

ProGnosis Biotech is an innovative biotechnology company, specialized in developing and manufacturing modern in-vitro testing technologies for use in the food, beverage, agriculture and clinical diagnostics markets.

Based in Greece, ProGnosis Biotech is an export-oriented enterprise which through a large network of distributors, exports ELISA kits and Lateral-flow tests to more than 62 countries worldwide.

The ELISA and Lateral flow tests offered by ProGnosis Biotech can detect mycotoxins in dairy, grains, and cereals, quantify histamine in fish and seafood, and detect the presence of allergens, adulteration and antibiotics in foods.

ProGnosis Biotech maintains high product quality by adhering to GMP and ISO standards and holds ISO 9001:2015 and ISO 13485:2016 certifications for Development, Manufacturing, and Marketing of Diagnostic and Laboratory Products.